Y-Intercept (HK)’s TELA Bio TELA Stock Holding History

Y-Intercept (HK)’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-63,316	Closed	-$298K	–	1790
2024 Q2	$298K	Buy	+63,316	New	+$334K	0.02%	1035

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Y-Intercept (HK)'s TELA Position: Q3 2024 in Review

Y-Intercept (HK) sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 63,316 shares — an estimated $298K sold.

Y-Intercept (HK) first reported a position in TELA in Q2 2024 and held it in 1 quarter. The position peaked at $298K in Q2 2024. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

Y-Intercept (HK) reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 63,316 TELA Bio shares in Q3 2024, an estimated $298K.
Y-Intercept (HK) first reported a position in TELA Bio in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s TELA Bio position peaked at $298K in Q2 2024.
49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.